Han R - Search Results

1

MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.

Han R, Zhao J, Lu L. Han R, et al. Oncol Rep. 2020 Jun;43(6):2062-2072. doi: 10.3892/or.2020.7549. Epub 2020 Mar 18. Oncol Rep. 2020. Retraction in: Oncol Rep. 2025 Jan;53(1):8. doi: 10.3892/or.2024.8841. PMID: 32186770 Retracted.

2

MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3.

Han R, Chen X, Li Y, Zhang S, Li R, Lu L. Han R, et al. Cancer Manag Res. 2019 Apr 10;11:2963-2976. doi: 10.2147/CMAR.S202664. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114344 Free PMC article.

3

Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications.

Shi F, Li Y, Han R, Fu A, Wang R, Nusbaum O, Qin Q, Chen X, Hou L, Zhu Y. Shi F, et al. Among authors: han r. Sci Rep. 2021 Jan 28;11(1):2519. doi: 10.1038/s41598-021-81620-x. Sci Rep. 2021. PMID: 33510252 Free PMC article.

4

Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Han R, Yang H, Lu L, Lin L. Han R, et al. Sci Rep. 2021 Apr 21;11(1):8626. doi: 10.1038/s41598-021-88133-7. Sci Rep. 2021. Retraction in: Sci Rep. 2025 Jul 29;15(1):27590. doi: 10.1038/s41598-025-11770-9. PMID: 33883691 Free PMC article. Retracted.

5

Neurospora crassa is a potential source of anti-cancer agents against breast cancer.

Han R, Yang H, Ling C, Lu L. Han R, et al. Breast Cancer. 2022 Nov;29(6):1032-1041. doi: 10.1007/s12282-022-01383-9. Epub 2022 Jul 5. Breast Cancer. 2022. PMID: 35881300

6

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment.

Han R, Li J, Hony J, Xiao Z, Wang J, Yao M, Liang S, Lu L. Han R, et al. Front Immunol. 2023 Mar 16;14:1052657. doi: 10.3389/fimmu.2023.1052657. eCollection 2023. Front Immunol. 2023. PMID: 37006233 Free PMC article. Review.

7

[Retracted] MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.

Han R, Zhao J, Lu L. Han R, et al. Oncol Rep. 2025 Jan;53(1):8. doi: 10.3892/or.2024.8841. Epub 2024 Nov 14. Oncol Rep. 2025. PMID: 39540400 Free PMC article.

8

Apoptotic protease activating factor-1 negatively regulates Wnt signaling in hepatocellular carcinoma.

Han R, Chen XY. Han R, et al. Kaohsiung J Med Sci. 2019 Aug;35(8):459-466. doi: 10.1002/kjm2.12089. Epub 2019 May 15. Kaohsiung J Med Sci. 2019. PMID: 31094091 Free PMC article.

9

GARS is implicated in poor survival and immune infiltration of hepatocellular carcinoma.

Wang J, Yang B, Wang D, Han R, Bi Z, Lin L. Wang J, et al. Among authors: han r. Cell Signal. 2022 Jun;94:110302. doi: 10.1016/j.cellsig.2022.110302. Epub 2022 Mar 7. Cell Signal. 2022. PMID: 35271987

10

Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor.

Han R, Nusbaum O, Chen X, Zhu Y. Han R, et al. Mol Ther Oncolytics. 2020 Aug 29;19:8-18. doi: 10.1016/j.omto.2020.08.017. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33024815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,560 results

Search Page

Filters